Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

20
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

52
Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
52
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

22
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
22
Nervous Tissue: Myelin01:25

Nervous Tissue: Myelin

12.1K
The myelin sheath is a multilayered lipid and protein covering that insulates the axon of a neuron, enhancing the speed of nerve impulse conduction. Axons without this sheath are referred to as unmyelinated. Two types of neuroglia, Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS) are responsible for producing myelin sheaths.
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
12.1K
Spinal Cord: Cross-sectional Anatomy01:16

Spinal Cord: Cross-sectional Anatomy

5.7K
The cross-sectional anatomy of the spinal cord offers a detailed view of its complex structure and function within the central nervous system. At the core of the spinal cord lies the gray matter, characterized by its butterfly or "H"-shaped appearance in cross-section. This central region is enveloped by white matter, with the overall structure divided into symmetrical halves by the dorsal median sulcus and the ventral median fissure.
Gray Matter and its Components
Central to the gray matter is...
5.7K
Diphtheria01:28

Diphtheria

175
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
175

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ultrasound Measurement of Cervical Length at 36-36+6 Weeks' Gestational Age to Predict Spontaneous Onset of Labor and Mode of Delivery.

Cureus·2026
Same author

Effectiveness and safety of clobazam as add-on therapy in children after the failure of first antiseizure medicine: a sub-analysis of the ADD-ON study.

Epilepsy & behavior : E&B·2025
Same author

Polymorphism of Melanocortin Receptor Genes-Association with Inflammatory Traits and Diseases.

Diseases (Basel, Switzerland)·2025
Same author

Barriers to Early Hospital Presentation in Acute Stroke: Findings from a Cohort Study.

Annals of Indian Academy of Neurology·2025
Same author

Barriers to Early Hospital Presentation in Acute Stroke: Findings from a Cohort Study.

Annals of Indian Academy of Neurology·2025
Same author

Accuracy of a Noninvasive, Wearable, Wireless, ECG-Based, Intrapartum Monitoring Tool Against the Conventional Ultrasound-Based CTG.

Journal of obstetrics and gynaecology of India·2025

Related Experiment Video

Updated: May 1, 2026

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

29.7K

Combined central and peripheral demyelination.

Bindu Menon1, Saranjeet Singh Bedi1, G Uma Maheshwar Rao1

  • 1Department of Neurology, Narayana Medical College and Superspeciality Hospital, Nellore, Andhra Pradesh, India.

Journal of Neurosciences in Rural Practice
|April 18, 2014
PubMed
Summary
This summary is machine-generated.

This study presents a rare case of acquired central and peripheral demyelination in a patient with chronic autoimmune hepatitis (CAH). The patient showed significant improvement after high-dose steroid treatment.

Keywords:
Central pontine myelinolysischronic autoimmune hepatitischronic inflammatory demyelinating polyradiculoneuropathy

More Related Videos

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
04:55

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice

Published on: May 11, 2022

4.1K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.4K

Related Experiment Videos

Last Updated: May 1, 2026

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

29.7K
A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice
04:55

A Stably Established Two-Point Injection of Lysophosphatidylcholine-Induced Focal Demyelination Model in Mice

Published on: May 11, 2022

4.1K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.4K

Area of Science:

  • Neurology
  • Immunology
  • Hepatology

Background:

  • Chronic autoimmune hepatitis (CAH) is an immune-mediated liver disease.
  • Demyelinating disorders typically affect either the central or peripheral nervous system, but not both simultaneously in acquired cases.

Observation:

  • A 52-year-old male with CAH presented with a 4-month history of progressive motor weakness and areflexia, followed by recent drowsiness.
  • Neurological examination revealed pure motor areflexic quadriparesis.

Findings:

  • Neuroimaging and electrophysiological studies indicated concurrent central pontine myelinolysis (CPM) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).
  • This co-occurrence of central and peripheral demyelination in a CAH patient is unprecedented.

Implications:

  • This case highlights a potential, albeit rare, neurological complication associated with CAH.
  • Effective treatment with high-dose steroids suggests an immunomodulatory approach may benefit such complex cases.